Evidence map›Paper›PMID 27226730›Full record

ArticleOncoTargets and therapy2016

Shorter telomere length of T-cells in peripheral blood of patients with lung cancer.

Yaqin Qian, Tingting Ding, Lijuan Wei, Shui Cao, Lili Yang

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Silica-exposed patients with silicosis show shorter telomeres than do unexposed individuals: a pilot study in a population in southeastern Brazil.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Blood immune cell biomarkers in lung cancer.Clinical and experimental immunology · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yaqin QianDepartment of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, People's Republic of China; National Clinical Research Center of Cancer, Tianjin, People's Republic of China; Tianjin Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, People's Republic of China.
Tingting DingDepartment of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, People's Republic of China; National Clinical Research Center of Cancer, Tianjin, People's Republic of China; Tianjin Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, People's Republic of China.
Lijuan WeiNational Clinical Research Center of Cancer, Tianjin, People's Republic of China.
Shui CaoNational Clinical Research Center of Cancer, Tianjin, People's Republic of China; Tianjin Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, People's Republic of China; Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, People's Republic of China.
Lili YangDepartment of Immunology, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, People's Republic of China; National Clinical Research Center of Cancer, Tianjin, People's Republic of China; Tianjin Key Laboratory of Cancer Immunology and Biotherapy, Tianjin, People's Republic of China.
Tianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTelomere shortening occurs in tumor tissues and peripheral blood lymphocytes of many common human malignancies, including lung cancer, but its variation in T-cells has never been investigated. Thus, the aim of this study was to assess telomere length in T-cells and its correlation with the clinical characteristics of patients with lung cancer. PATIENTS AND

methodsA total of 40 patients with lung cancer but without prior cancer history and 25 healthy individuals were selected. T-cells were isolated and their telomere lengths were measured using quantitative real-time polymerase chain reaction methods.

resultsTelomere length in T-cells was significantly shorter in patients with lung cancer than in controls (P<0.001). Shorter telomere length was significantly associated with increased clinical stage (P=0.008) and distant metastasis (P=0.028). Naïve T-cells from patients with lung cancer had significantly decreased telomere length when compared with those from controls (P=0.012).

conclusionThe shortened telomere length in T-cells occurred in naïve T-cells and might be related to lung cancer progression.

Indexed as

immunocompromisenaïve T-celltelomere’s activitytelomere shorteningT lymphocytestumor

Identifiers

PMID27226730
PMCPMC4863689
OpenAlexW2345403596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.